Hepatitis B Tests Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Hepatitis B
- Increasing Awareness Among People About Early Detection of the Disease
Challenges
- Lack of Awareness Regarding Hepatitis B Tests in Lower Economic Regions
Hepatitis B Tests Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.8% |
|
Base Year Market Size (2024) |
USD 1.41 billion |
|
Forecast Year Market Size (2037) |
USD 2.93 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of hepatitis B tests is assessed at USD 1.48 billion.
Hepatitis B Tests Market size was valued at USD 1.41 billion in 2024 and is expected to reach USD 2.93 billion by 2037, registering around 5.8% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is anticipated to account for largest revenue share by 2037, backed by large number of patients, and growing occurrence of hepatitis in the region.
The major players in the market are Abbott Laboratories, F. Hoffman-La Roche AG, Siemens AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and others.
